Equities

Luye Pharma Group Ltd

Luye Pharma Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)2.85
  • Today's Change0.03 / 1.06%
  • Shares traded13.39m
  • 1 Year change-25.97%
  • Beta1.2899
Data delayed at least 15 minutes, as of Nov 08 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income700670(75)
Depreciation/depletion378367343
Non-Cash items399455661
Cash taxes paid, supplemental13293271
Cash interest paid, supplemental472369297
Changes in working capital(206)(142)(986)
Total cash from operations1,5951,654182
INVESTING
Capital expenditures(1165)(1164)(1542)
Other investing and cash flow items, total(253)(495)(1894)
Total cash from investing(1418)(1658)(3436)
FINANCING
Financing cash flow items3977201,241
Total cash dividends paid----0
Issuance (retirement) of stock, net92301,044
Issuance (retirement) of debt, net(478)(666)(406)
Total cash from financing842541,879
NET CHANGE IN CASH
Foreign exchange effects(104)(164)(52)
Net change in cash915(115)(1427)
Net cash-begin balance/reserved for future use2,3242,4383,865
Net cash-end balance/reserved for future use3,2392,3242,438
SUPPLEMENTAL INCOME
Depreciation, supplemental378367343
Cash interest paid, supplemental472369297
Cash taxes paid, supplemental13293271
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.